Is there an androgen level threshold for aneuploidy risk in infertile women?

Reproductive Biology and Endocrinology

Research

Mark M Kushnir¹  Nandita Ganguly²  Kara N Goldman²  James A Grifo²  David H McCulloh²  Vitaly A Kushnir³  David F Albertini³  David H Barad⁴  Norbert Gleicher⁴ 

[1] ARUP Institute for Clinical and Experimental Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA;Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA;New York University Fertility Center, New York University School of Medicine, 10016, New York, New York, USA;The Center for Human Reproduction, 10021, New York, New York, USA;The Center for Human Reproduction, 10021, New York, New York, USA;The Foundation for Reproductive Medicine, 10021, New York, New York, USA;

关键词: Androgens;    Aneuploidy;    Preimplantation genetic diagnosis (PGS);    in vitro fertilization (IVF);   

DOI  :  10.1186/s12958-015-0034-z

 received in 2014-12-09, accepted in 2015-04-24,  发布年份 2015

来源: Springer

【 摘 要 】

BackgroundLow functional ovarian reserve (LFOR) has been associated with hypoandrogenemia and increased embryo aneuploidy, while androgen supplementation has been reported to improve aneuploidy rates. We, therefore, assessed whether in infertile women undergoing in vitro fertilization (IVF) androgen concentrations are associated with aneuploidy rates.MethodsThis study was performed in 2 academically affiliated fertility centers in New York City and an academically affiliated steroid chemistry laboratory in Utah. Androgen concentrations were measured in blinded fashion from 84 infertile women (age 40.3 +/− 2.4 years) at New York University (NYU), using a validated LC-MS/MS method, in cryopreserved serum samples of patients who had undergone IVF with concomitant preimplantation genetic screening (PGS), utilizing a 24-chromosome platform. The Center for Human Reproduction (CHR) provided plasma samples of 100 historical controls (ages 38.6+/−5.0 years) undergoing IVF without PGS. Statistical comparisons were made of androgen concentrations, and of associations between androgen concentrations and embryo aneuploidy.ResultsWomen undergoing IVF + PGS at NYU revealed no association between embryo aneuploidy and androgen concentrations but demonstrated significantly lower androgen concentrations than the 100 control patients from CHR,ConclusionsThough this study revealed no association between androgen levels and embryo ploidy, the extremely low androgen levels in the NYU study group raise the possibility of a threshold effect below which testosterone no longer affects aneuploidy. Before an androgen effect on embryo ploidy can be completely ruled out, a patient population with more normal androgen levels has to be investigated.

【 授权许可】

CC BY   
© Gleicher et al.; licensee BioMed Central. 2015